Immunomodulation by Hemoadsorption-Changes in Hepatic Biotransformation Capacity in Sepsis and Septic Shock : a prospective study.
Argitaratua izan da: | Biomedicines 10(2022)10, S. 2340 |
---|---|
Egile Nagusiak: | Praxenthaler, Janina (Egilea), Schwier, Elke (Egilea), Altmann, Simon (Egilea), Kirchner, Carmen (Egilea), Henzler, Dietrich (Egilea), Köhler, Thomas (Egilea) |
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
2022
|
Gaiak: | |
Sarrera elektronikoa: | https://pubmed.ncbi.nlm.nih.gov/36289602/ https://doi.org/10.3390/biomedicines10102340 |
Antzeko dokumentuak: | In:
Biomedicines |
Antzeko izenburuak
-
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
nork: Köhler, Thomas, et al.
Argitaratua: (2022) -
Case report: Early detection of mesenteric ischemia by intravital microscopy in a patient with septic shock
nork: Praxenthaler, Janina, et al.
Argitaratua: (2022) -
High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock : a retrospective cohort study
nork: Schultz, Philipp, et al.
Argitaratua: (2021) -
Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb-Basics, Indications and Perspectives-A Scoping Review
nork: Köhler, Thomas, et al.
Argitaratua: (2021) -
Profound decrease of liver maximum function capacity test of isoflurane sedated patients : a report of three cases
nork: Schwier, Elke, et al.
Argitaratua: (2021)